Lv5
804 积分 2022-12-02 加入
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
2天前
已完结
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial
2天前
已完结
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
14天前
已完结
Tirzepatide: First Approval
19天前
已完结
Treat-to-target in systemic lupus erythematosus: advancing towards its implementation
2个月前
已完结
Evaluation of systemic lupus erythematosus activity: an update
3个月前
已完结
The Systemic Lupus Erythematosus Responder Index (SRI); A new SLE disease activity assessment
3个月前
已完结
皖公网安备34019202002308
